NCT01937377View on ClinicalTrials.gov

GLORIA-AF Registry Program (Phase II/III)

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 2, 2013

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions
StrokeAtrial Fibrillation
Trial Locations (5)

1011

CHUV - Centre hospitalier universitaire vaudois, Lausanne

3322

Arzte Zentrum Eigerpark, Urtenen-Schonbuhl, Schönbühl

4031

University Hospital Basel, Basel

9007

Kantonsspital St.Gallen, Sankt Gallen

CH-6900

Cardiocentro Ticino, Lugano

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01937377 - GLORIA-AF Registry Program (Phase II/III) | Biotech Hunter | Biotech Hunter